
|Videos|June 17, 2016
Clinical Data Preceding ACC/AHA Updated Heart Failure Guidelines
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, discusses the investigations that preceded the ACC/AHA Updated Heart Failure Guidelines
Advertisement
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, discusses the investigations that preceded the ACC/AHA Updated Heart Failure Guidelines
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups
2
Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk
3
SGLT2 Inhibitors Linked to Lower Atrial Fibrillation Risk, Recurrence
4
Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies
5












































































































































































































